Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

492
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
492
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.2K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

744
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
744
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

796
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
796
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

2.4K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.4K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.6K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary surgical bleeding and platelet function are unchanged in heartworm-infected dogs.

Frontiers in veterinary science·2026
Same author

Comparison of adsorptive capacity for different types of activated charcoal for common veterinary toxicants.

Frontiers in veterinary science·2026
Same author

Acute kidney injury is associated with increased mortality in dogs with gastric dilatation and volvulus.

Journal of the American Veterinary Medical Association·2026
Same author

Correction: Anticoagulant therapy and altered tissue factor expression protect against experimental placental and cerebral malaria.

PLoS pathogens·2025
Same author

A Prospective Multicenter Observational Study Assessing Incidence and Risk Factors for Acute Transfusion Reactions in Cats.

Journal of veterinary internal medicine·2025
Same author

Associations Among Various Physical Parameters and the Axillary-to-Rectal Temperature Difference in Dogs and Cats.

Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)·2025

Related Experiment Video

Updated: Mar 27, 2026

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
05:52

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

Published on: November 4, 2021

3.5K

Cardiogenic embolism in the cat.

Daniel F Hogan1, Benjamin M Brainard2

  • 1Purdue University, College of Veterinary Medicine, Department of Veterinary Clinical Sciences, 625 Harrison Street, West Lafayette, IN 47907-2026, USA.

Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology
|January 19, 2016
PubMed
Summary

Cardiogenic embolism (CE) in cats, a common cause of death, lacks effective prevention strategies. Recent studies offer hope for improved outcomes in feline arterial thromboembolism.

Keywords:
FelineInfarctionStrokeThromboprophylaxisThrombosis

More Related Videos

Identification of Neutrophil Extracellular Traps in Paraffin-Embedded Feline Arterial Thrombi using Immunofluorescence Microscopy
08:48

Identification of Neutrophil Extracellular Traps in Paraffin-Embedded Feline Arterial Thrombi using Immunofluorescence Microscopy

Published on: March 29, 2020

9.4K
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

957

Related Experiment Videos

Last Updated: Mar 27, 2026

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
05:52

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

Published on: November 4, 2021

3.5K
Identification of Neutrophil Extracellular Traps in Paraffin-Embedded Feline Arterial Thrombi using Immunofluorescence Microscopy
08:48

Identification of Neutrophil Extracellular Traps in Paraffin-Embedded Feline Arterial Thrombi using Immunofluorescence Microscopy

Published on: March 29, 2020

9.4K
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

957

Area of Science:

  • Veterinary Medicine
  • Cardiology
  • Thrombosis

Background:

  • Cardiogenic embolism (CE), also known as saddle thrombus or feline arterial thromboembolism, is a significant cause of mortality in cats with heart disease.
  • Despite decades of clinical observation, advancements in preventing or treating CE in cats have been limited.
  • A lack of data identifying specific risk factors beyond underlying heart disease hinders proactive management.

Purpose of the Study:

  • To review the current understanding of CE in cats as of 2015.
  • To summarize clinical presentation, survival rates, and thrombotic risks associated with feline arterial thromboembolism.
  • To discuss current and potential strategies for the prevention of cardiogenic embolism in cats.

Main Methods:

  • Review of existing literature on feline cardiogenic embolism.
  • Analysis of clinical data regarding presentation, survival, and risk factors.
  • Evaluation of recent thromboprophylactic studies and antithrombotic drug development.

Main Results:

  • The first prospective study on thromboprophylaxis in feline arterial thromboembolism has been completed.
  • Challenges remain in developing species-specific antithrombotic drugs for cats.
  • Identifying cats at high risk for CE beyond having heart disease is still an area needing more research.

Conclusions:

  • Significant progress in preventing or improving outcomes for feline cardiogenic embolism is still needed.
  • Further research and pharmaceutical focus are crucial for advancing feline arterial thromboembolism treatment and prevention.
  • A comprehensive understanding of risk factors and effective thromboprophylaxis is essential for feline cardiac health.